Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 20-Oct-2022
No. of pages: 103

The report focuses on the PARP (Poly ADP-ribose Polymerase) Inhibitors market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the PARP (Poly ADP-ribose Polymerase) Inhibitors market.

Major Players in the PARP (Poly ADP-ribose Polymerase) Inhibitors market are:

AstraZeneca

Merck and Co

Tesaro

Pfizer

Clovis Oncology

On the basis of types, the PARP (Poly ADP-ribose Polymerase) Inhibitors market is primarily split into:

Lynparza

Zejula

Rubraca

Talzenna

Other

On the basis of applications, the market covers:

Ovarian Cancer

Breast Cancer

Other

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Overview
1.1 Product Overview and Scope of PARP (Poly ADP-ribose Polymerase) Inhibitors Market
1.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Segment by Type
1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Segment by Application
1.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of PARP (Poly ADP-ribose Polymerase) Inhibitors (2017-2029)
1.5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Revenue Status and Outlook (2017-2029)
1.5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the PARP (Poly ADP-ribose Polymerase) Inhibitors Industry
1.7 Impact of Carbon Neutrality on the PARP (Poly ADP-ribose Polymerase) Inhibitors Industry

2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Upstream and Downstream Analysis
2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of PARP (Poly ADP-ribose Polymerase) Inhibitors Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 AstraZeneca
3.1.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Merck and Co
3.2.1 Merck and Co Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Tesaro
3.3.1 Tesaro Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Pfizer
3.4.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Clovis Oncology
3.5.1 Clovis Oncology Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance (2017-2022)
3.5.4 Business Overview

4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Landscape by Player
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Share by Player (2017-2022)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Market Share by Player (2017-2022)
4.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Average Price by Player (2017-2022)
4.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Gross Margin by Player (2017-2022)
4.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Competitive Situation and Trends
4.5.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Rate
4.5.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price Trend by Type
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Market Share by Type (2017-2022)
5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Market Share by Type (2017-2022)
5.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Price by Type (2017-2022)
5.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate of Lynparza (2017-2022)
5.4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate of Zejula (2017-2022)
5.4.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate of Rubraca (2017-2022)
5.4.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate of Talzenna (2017-2022)
5.4.5 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Growth Rate of Other (2017-2022)

6 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis by Application
6.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Market Share by Application (2017-2022)
6.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate of Ovarian Cancer (2017-2022)
6.3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate of Breast Cancer (2017-2022)
6.3.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption and Growth Rate of Other (2017-2022)

7 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Region Wise (2017-2022)
7.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Market Share, Region Wise (2017-2022)
7.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Market Share, Region Wise (2017-2022)
7.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Forecast (2022-2029)
8.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue Forecast (2022-2029)
8.1.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Price and Trend Forecast (2022-2029)
8.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.4 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.5 India PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Sales and Revenue Forecast (2022-2029)
8.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate of Lynparza (2022-2029)
8.3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate of Zejula (2022-2029)
8.3.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate of Rubraca (2022-2029)
8.3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate of Talzenna (2022-2029)
8.3.5 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate of Other (2022-2029)
8.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Forecast by Application (2022-2029)
8.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Value and Growth Rate of Ovarian Cancer (2022-2029)
8.4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Value and Growth Rate of Breast Cancer (2022-2029)
8.4.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Consumption Value and Growth Rate of Other (2022-2029)
8.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Forecast Under COVID-19

9 Industry Outlook
9.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers Analysis
9.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints and Challenges
9.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs